Edition:
United Kingdom

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

1,854.30INR
11:17am BST
Change (% chg)

Rs3.30 (+0.18%)
Prev Close
Rs1,851.00
Open
Rs1,853.35
Day's High
Rs1,879.90
Day's Low
Rs1,850.25
Volume
3,071
Avg. Vol
14,948
52-wk High
Rs2,397.70
52-wk Low
Rs1,306.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 1,902.98 3.931
Dec 2,151.94 11.640
Sep 1,613.61 3.653
Jun 1,614.37 2.560
FY 2018 Mar '18 1,507.27 1.287
Dec 1,285.39 -4.141
Sep 1,642.58 10.954
Jun 1,284.66 2.320
FY 2017 Mar '17 1,168.86 -3.826
Dec 1,515.02 6.484
Sep 1,394.06 0.315
Jun 1,408.65 5.041
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 120.54 29.88 32.67
P/E High - Last 5 Yrs. 548.94 42.96 47.29
P/E Low - Last 5 Yrs. 95.66 23.36 23.88
Beta 0.50 0.89 0.89
Price to Sales (TTM) 4.49 6.26 7.92
Price to Book (MRQ) -- 5.26 5.39
Price to Tangible Book (MRQ) -- 5.93 6.71
Price to Cash Flow (TTM) 67.54 23.51 24.37
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) 0.00 42.62 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.80 5.12 12.24
Sales (TTM) vs TTM 1 Yr. Ago -7.71 6.49 7.74
Sales - 5 Yr. Growth Rate 0.30 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -53.97 40.64 43.01
EPS (TTM) vs TTM 1 Yr. Ago 30.10 -- --
EPS - 5 Yr. Growth Rate 4.34 9.79 10.32
Capital Spending - 5 Yr. Growth Rate -32.37 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.95 10.21
Total Debt to Equity (MRQ) -- 11.64 14.56
Interest Coverage (TTM) -- 32.88 29.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 66.88 51.83 52.21
Gross Margin - 5 Yr. Avg. 58.94 49.67 50.40
EBITD Margin (TTM) 3.71 -- --
EBITD - 5 Yr. Avg -1.89 17.40 13.16
Operating Margin (TTM) 0.79 13.79 6.88
Operating Margin - 5 Yr. Avg. -3.91 13.96 8.97
Pre-Tax Margin (TTM) 5.09 12.42 6.08
Pre-Tax Margin - 5 Yr. Avg. -2.10 14.37 9.26
Net Profit Margin (TTM) 3.72 9.21 2.72
Net Profit Margin - 5 Yr. Avg. -3.27 10.80 5.63
Effective Tax Rate (TTM) 26.88 22.44 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 4,631,859 993,638,344 887,716,663
Net Income/Employee (TTM) 172,405 114,094,014 101,894,138
Receivable Turnover (TTM) -- 5.96 5.94
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.51 11.18
Return on Assets - 5 Yr. Avg. -4.28 12.96 12.34
Return on Investment (TTM) -- 14.90 14.49
Return on Investment - 5 Yr. Avg. -10.35 16.86 16.03
Return on Equity (TTM) -- 16.02 15.79
Return on Equity - 5 Yr. Avg. -10.64 17.66 17.02
  1 Year 3 Year 5 Year
Sales % -4.29 4.42 0.30
EPS (TTM) % 364.77 -- 4.34
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Astrazeneca Pharma India Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.27 1.86 99 23
13 Week -4.17 -5.54 99 42
26 Week 0.58 -6.08 99 42
52 Week 0.44 -11.26 99 12
YTD 2.48 -14.23 99 38
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.64%
# of Holders: 9
Total Shares Held: 1,160,993
3 Mo. Net Change: 21,698
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.